白血病的概述

1.  Zuckerman T, Rowe JM. Pathogenesis and prognostication in acute lymphoblastic leukemia. F1000Prime Rep. 2014;6:59.

• 全文
• 摘要

2.  Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med. 2004;350:1535-1548.

• 摘要

3.  Hallek M. State-of-the-art treatment of chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2009:440-449.

• 全文
• 摘要

4.  Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) updating the National Cancer Institute-Working Group (NCI-WG) 1996 guidelines. Blood. 2008;111:5446-5456.

• 全文
• 摘要

5.  Eichhorst B, Robak T, Montserrat E, et al. Chronic lymphocytic leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(suppl 5):78-84.

• 全文
• 摘要

6.  Howlader N, Noone AM, Krapcho M, et al, eds. Table 13.13: Myeloid leukemia: SEER Incidence rates, age-adjusted and age-specific Rates, by race and sex. In: SEER Cancer Statistics Review, 1975-2011. Bethesda, MD: National Cancer Institute; 2014. Based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

• 全文

7.  Chen Y, Kantarjian H, Wang H, et al. Acute promyelocytic leukemia: a population-based study on incidence and survival in the United States, 1975-2008. Cancer. 2012;118:5811-5818.

• 全文
• 摘要

8.  Sawyers C. Chronic myeloid leukemia. N Engl J Med. 1999;341:1330-1340.

• 摘要

9.  Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-130.

• 摘要

10.  Faderl S, Talpaz M, Estrov Z, et al. The biology of chronic myeloid leukemia. N Engl J Med. 1999;341:164-172.

• 摘要

11.  Savage DG, Szydlo RM, Goldman JM. Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period. Br J Haematol. 1997;96:111-116.

• 摘要

12.  Baccarani M, Pileri S, Steegmann JL, et al. Chronic myeloid leukemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(suppl 7):vii72-vii77.

• 全文
• 摘要

13.  Jones G, Parry-Jones N, Wilkins B, et al. Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant*. Br J Haematol. 2012;156:186-195.

• 全文
• 摘要

14.  Hoffman MA. Clinical presentations and complications of hairy cell leukemia. Hematol Oncol Clin North Am. 2006;20:1065-1073.

• 摘要